NeOnc Technologies Holdings, Inc. (NTHI)
3.19
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:36
NeOnc Technologies Holdings Enterprise Value : 77.89M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 77.89M |
| November 04, 2026 | 77.14M |
| November 03, 2026 | 74.66M |
| November 02, 2026 | 74.66M |
| October 30, 2026 | 79.38M |
| October 29, 2026 | 75.90M |
| October 28, 2026 | 73.66M |
| October 27, 2026 | 72.92M |
| October 26, 2026 | 68.44M |
| October 23, 2026 | 79.63M |
| October 22, 2026 | 71.67M |
| October 21, 2026 | 70.43M |
| October 20, 2026 | 67.20M |
| October 19, 2026 | 65.96M |
| October 16, 2026 | 65.46M |
| October 15, 2026 | 66.70M |
| October 14, 2026 | 64.47M |
| October 13, 2026 | 62.85M |
| October 12, 2026 | 66.21M |
| October 09, 2026 | 67.45M |
| October 08, 2026 | 61.23M |
| October 07, 2026 | 65.71M |
| October 06, 2026 | 72.67M |
| October 05, 2026 | 70.93M |
| October 02, 2026 | 72.67M |
| Date | Value |
|---|---|
| October 01, 2026 | 74.41M |
| September 30, 2026 | 82.98M |
| September 29, 2026 | 80.37M |
| September 28, 2026 | 76.89M |
| September 25, 2026 | 80.62M |
| September 24, 2026 | 80.37M |
| September 23, 2026 | 78.38M |
| September 22, 2026 | 84.10M |
| September 21, 2026 | 81.12M |
| September 18, 2026 | 79.38M |
| September 17, 2026 | 83.11M |
| September 16, 2026 | 72.67M |
| September 15, 2026 | 80.62M |
| September 14, 2026 | 92.30M |
| September 11, 2026 | 89.82M |
| September 10, 2026 | 89.32M |
| September 09, 2026 | 88.33M |
| September 08, 2026 | 99.51M |
| September 04, 2026 | 123.37M |
| September 03, 2026 | 117.40M |
| September 02, 2026 | 121.63M |
| September 01, 2026 | 115.91M |
| August 31, 2026 | 121.13M |
| August 28, 2026 | 114.92M |
| August 27, 2026 | 112.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 12.89M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| Arvinas, Inc. | -121.78M |
| Fulcrum Therapeutics, Inc. | -32.83M |
| Definium Therapeutics, Inc. | 3.032B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.24M |
| Total Expenses (Quarterly) | 14.24M |
| EPS Diluted (Quarterly) | -0.5774 |
| Earnings Yield | -66.47% |
| Normalized Earnings Yield | -65.67 |